Individual clinicians can lead efforts to build trust in science and distribute accurate information, but medical schools also have an important role to play in training health care professionals to communicate with the public, according to Vineet Arora, MD, MAPP, dean for medical education at UChicago Medicine.
Individual clinicians can lead efforts to build trust in science and distribute accurate information, but medical schools also have an important role to play in training health care professionals to communicate with the public, according to Vineet Arora, MD, MAPP, dean for medical education at UChicago Medicine.
Transcript
Can you discuss some takeaways of your work on how health care professionals can address misinformation and build trust in science?
Yeah, so during the pandemic, I actually had a baby during the pandemic, March 30th of 2020. So yeah, think about what you were doing at that time and what I was doing! And, you know, while my husband is the head of the hospitalist program, standing up COVID units, I was having a baby in our obstetrics unit. Being on the sidelines was very hard, and so I wanted to contribute, but I noticed that I actually had a role in my community. While I was interacting with my neighbors and people while I was at home, I was realizing that a lot of the information that people were getting and I was still seeing on email in the hospital was just not permeating to my neighborhood or my nonmedical friends. And in fact, they were getting a lot of information, bad information from other sources.
And so I really started to think closely about how I can use my platform to lead in that space and starting to think about how we can do a better job of making sure people get good information. So, along with several of my colleagues across Chicagoland and other academic centers and in the community, we started a program called IMPACT, Illinois Medical Professionals Action Collaborative Team, to really put out good information and also address and crowdsource needs like helping vaccinate hardest-hit communities in Chicago, all volunteer based through a nonprofit that continues today.
Then through that, I started to think as I became dean for medical education and sort of transitioned out of that role into this one, as the Surgeon General was declaring misinformation a public health crisis, what is it that medical schools should do and health professional schools should do to address misinformation? We know that if we don’t teach our clinicians to communicate well to the public, it could actually make misinformation worse. And so, one of the things we started doing here is pioneering courses to teach about scientific literacy and communication to the public with a science communicator.
It's been very exciting to do this work, but also to see students and nurses now and pharmacists, as we’ve expanded with an Association of American Medical Colleges grant to include other disciplines, and see how this training not just empowers frontline clinicians to have these conversations around vaccines or reproductive health or whatever it is, but also makes them feel better about their ability to address the situation in their community and with their patients. And so, I’m very excited about that workstream and hope it continues.
As Claims Denials Surge, AI and Data-Driven Insights Equip Clinicians, Hospitals to Fight Back
March 13th 2025As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in shaping the future of patient care, according to experts from Komodo Health and SmarterDx.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More
Advancing HIV Care With Doravirine and Islatravir: Q&A With Amy Colson, MD, MPH
March 12th 2025New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically suppressed people living with HIV-1, were presented today by Amy Colson, MD, MPH.
Read More